Serial brain (18)FDG-PET in anti-AMPA receptor limbic encephalitis.


Autoria(s): Spatola M.; Stojanova V.; Prior J.O.; Dalmau J.; Rossetti A.O.
Data(s)

2014

Resumo

Immunotherapy-responsive autoimmune CNS syndromes linked to antibodies targeting surface neuronal antigens lack reliable biomarkers of disease activity. We report serial cerebral (18)FDG PET studies in a woman with AMPA receptor (AMPA-R) autoimmune limbic encephalitis. During her follow-up, despite an aggressive immunotherapy, she displayed a persistent, predominantly left hippocampal FDG hypermetabolism, in the absence of CNS inflammatory signs. Brain metabolism abnormalities regressed after increasing antiepileptic treatment, correlating with a moderate clinical improvement. Brain (18)F-FDG PET could thus represent a useful complementary tool to orient the clinical follow-up.

Identificador

http://serval.unil.ch/?id=serval:BIB_BCB068E97D53

isbn:1872-8421 (Electronic)

pmid:24793897

doi:10.1016/j.jneuroim.2014.04.002

isiid:000337207700008

Idioma(s)

en

Fonte

Journal of Neuroimmunology, vol. 271, no. 1-2, pp. 53-55

Tipo

info:eu-repo/semantics/article

article